Search For "pedro m folegatti"
Domestic pharma giant SII applies to DCGI for phase 2/3 clinical trial of
Updated : 5 years, 8 months ago IST
New Delhi [India], July 25 (ANI): In a development related to the COVID-19 vaccine, the Serum Institute of India (SII) has applied to the Drugs Controller General of India (DCGI) for conducting the Phase 2/3 human clinical trials for a potential coronavirus vaccine.
Read More
Oxford's coronavirus vaccine 'safe, immunogenic': Study
Updated : 5 years, 8 months ago IST
London [UK], July 20 (ANI): A vaccine candidate developed at the University of Oxford has shown encouraging results in early human testing and appears to be "safe well-tolerated, and immunogenic", according to a study published in The Lancet.
Read More